Dr. Reimers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 S Euclid Ave
Saint Louis, MO 63110Phone+1 800-600-3606- Is this information wrong?
Summary
- I am a board certified medical oncologist specializing in genitourinary oncology. I primarily treat patients with prostate, bladder, and kidney cancers. My main research focus is in clinical trial development.
Education & Training
- University of North Carolina HospitalsResidency, Internal Medicine, 2013 - 2016
- Saint Louis University School of MedicineClass of 2013
Certifications & Licensure
- IL State Medical License 2020 - 2026
- MO State Medical License 2019 - 2025
- MI State Medical License 2016 - 2020
- NC State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations Start of enrollment: 2018 Dec 14
- Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial) Start of enrollment: 2021 Feb 19
- Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer Start of enrollment: 2024 Apr 30
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Yige Wu, Nadezhda V Terekhanova, Wagma Caravan, Nataly Naser Al Deen, Preet Lal, Siqi Chen, Chia-Kuei Mo, Song Cao, Yize Li, Alla Karpova, Ruiyang Liu, Yanyan Zhao, An...> ;Nature Communications. 2023 May 17
- 11 citationsEpigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.Yige Wu, Nadezhda V Terekhanova, Wagma Caravan, Nataly Naser Al Deen, Preet Lal, Siqi Chen, Chia-Kuei Mo, Song Cao, Yize Li, Alla Karpova, Ruiyang Liu, Yanyan Zhao, An...> ;Nature Communications. 2023 Mar 27
- 39 citationsHistopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness.Yize Li, Tung-Shing M Lih, Saravana M Dhanasekaran, Rahul Mannan, Lijun Chen, Marcin Cieslik, Yige Wu, Rita Jiu-Hsien Lu, David J Clark, Iga Kołodziejczak, Runyu Hong,...> ;Cancer Cell. 2023 Jan 9
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Siteman Cancer CenterSaint Louis, Missouri
- Barnes-Jewish West County HospitalSaint Louis, Missouri
- Barnes-Jewish HospitalSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: